• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Asia Pacific Insomnia Market Analysis

    ID: MRFR/Pharma/0176-HCR
    50 Pages
    Kinjoll Dey
    October 2025

    Asia Pacific Insomnia Market Research Report, By Types Of Therapy (Pharmacological Therapy And Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablet And Others), By Type Of Diseases (Poor Quality Of Sleep, Sleep Maintenance And Other) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia Pacific Insomnia Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Asia Pacific Insomnia Market Industry Landscape

    The Asia Pacific district is seeing a rising frequency of insomnia, driven by elements like urbanization, developing ways of life, and expanded business related pressure. This has prompted a developing interest for powerful answers for address sleep issues in the district. Social perspectives towards sleep and lifestyle decisions assume a critical part in molding the insomnia market elements in Asia Pacific. The customary attention on difficult work and long working hours has added to a climate where sleep issues are progressively pervasive. The drug range remains a central participant in the Asia Pacific insomnia market. Sleep prescriptions and drug mediations are broadly acknowledged, and the market is beholding a surge in the improvement of new medications taking special care of the different population in the district. Aside from drug choices, there is an outstanding dependence on home grown and usual solutions for overseeing insomnia in Asia Pacific. Regular treatments, usual medication, and Ayurveda are gaining prevalence as people look for options with social significance. The Asia Pacific district is encountering a quick reception of computerized health answers for overseeing insomnia. Portable applications, wearable gadgets, and online platforms offering sleep following and remedial mediations are becoming indispensable parts of the market. The reception of telehealth for insomnia meetings is developing, particularly in geologically scattered regions. Remote observing and discussions furnish people in remote locales with admittance to specific consideration, adding to a more comprehensive way to deal with insomnia management. Organizations working in the Asia Pacific insomnia market are progressively perceiving the significance of social awareness in item advancement. Tailoring answers for line up with social inclinations and convictions is turning into a vital procedure for market achievement.

    Market Summary

    As per Market Research Future Analysis, the Asia Pacific Insomnia Market was valued at USD 0.14 Billion in 2023 and is projected to grow to USD 0.20 Billion by 2032, with a CAGR of 8.12% from 2024 to 2032. Insomnia, the most prevalent sleep disorder, affects a significant portion of the population, particularly women and younger individuals. Factors such as increased alcohol, caffeine, and tobacco consumption, along with psychological and behavioral issues, are driving the rise in insomnia cases. The market is further supported by technological advancements and rising healthcare expenditures. However, a lack of education and awareness may hinder growth.

    Key Market Trends & Highlights

    The Asia Pacific Insomnia Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 0.14 Billion
    • Projected Market Size by 2032: USD 0.20 Billion
    • CAGR from 2024 to 2032: 8.12%
    • Japan holds the largest market share, with 1 in 5 people affected by insomnia.

    Market Size & Forecast

    2023 Market Size USD 0.14 Billion
    2024 Market Size USD 0.18 Billion
    2032 Market Size USD 0.20 Billion
    CAGR 8.12%.

    Major Players

    Key players include Takeda Pharmaceutical Company, Pfizer, Inc., Eisai, Co., Merck & Co Inc, Sanofi, and GlaxoSmithKline Plc.

    Market Trends

    Asia Pacific Insomnia Market Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the Asia Pacific Insomnia Market market include

    Industry Developments

    Market Segmentation

    Asia Pacific Insomnia Market Segmentation

    Asia Pacific Insomnia Market Intended Audience
    • Manufacturing and packaging industries
    • Insomnia devices and drug manufacturers
    • Insomnia devices and drug suppliers
    • Biotechnology Companies
    • Bio-Pharmaceutical Companies
    • Research and Development (R&D) Companies
    • Government Research Laboratories
    • {" "=>[]}

    Report Scope

    Attribute/Metric Details
    Market Size USD 0.20 Billion by 2032
    CAGR 8.12% (2024-2032)
    Base Year   2023
    Forecast Period   2024-2032
    Historical Data   2021
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered Asia Pacific
    Key Vendors Takeda Pharmaceutical Company (Japan), Pfizer, Inc. (US), Eisai, Co. (Japan),  Merck & Co Inc (US), Sanofi (France),  GlaxoSmithKline Plc. (UK), Meda Consumer Healthcare Inc (US), Care Fusion Corporation (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK)

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table of Contents 1    INTRODUCTION    
      1.     DEFINITION    
      2.     SCOPE OF STUDY    
        1.     RESEARCH OBJECTIVE    
        2.     ASSUMPTIONS & LIMITATIONS    
      3.     MARKET STRUCTURE:    
    2. 2    Research Methodology    
      1.     RESEARCH PROCESS:    
      2.     PRIMARY RESEARCH    
      3.     SECONDARY RESEARCH:    
    3. 3    MARKET DYNAMICS    
      1.     DRIVERS    
      2.     RESTRAINTS        
      3.     OPPORTUNITIES    
      4.     MACROECONOMIC INDICATORS    
    4. 4    MARKET FACTOR ANALYSIS    
      1.     PORTERS FIVE FORCES MODEL    
      2.     BARGAINING POWER OF SUPPLIERS    
      3.     BARGAINING POWER OF BUYERS    
      4.     THREAT OF NEW ENTRANTS    
      5.     THREAT OF SUBSTITUTES    
      6.     INTENSITY OF RIVALRY    
    5.     ASIA PACIFIC INSOMNIA MARKET, BY TYPES OF THERAPY 
      1.     PHARMACOLOGICAL THERAPY 
        1.     BENZODIAZEPINES
        2.     NON-BENZODIAZEPINES
        3.     MELATONIN RECEPTOR AGONISTS 
        4.     OTHER
      2.     NON PHARMACOLOGICAL THERAPY 
        1.     RELAXATION THERAPY
        2.     COGNITIVE BEHAVIORAL THERAPY
        3.     SLEEP HYGIENE EDUCATION
        4.     STIMULUS CONTRO
        5.     PARADOXICAL INTENTION 
        6.     OTHER
    6.     ASIA PACIFIC INSOMNIA MARKET, BY DRUG FORMULATION 
      1.     CAPSULES
      2.     TABLET 
      3.     OTHERS.
    7.     ASIA PACIFIC INSOMNIA MARKET, BY TYPE OF DISEASE
      1.     POOR QUALITY OF SLEEP
      2.     SLEEP MAINTENANCE 
      3.     OTHER.
    8.     GLOBAL INSOMNIA MARKET, BY REGION
      1.     INTRODUCTION
        1.     JAPAN
        2.     CHINA
        3.     INDIA
        4.     AUSTRALIA
        5.     REPUBLIC OF KOREA
        6.     REST OF ASIA-PACIFIC
    9.     Competitive Landscape    
      1.     MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    
        1.     STRATEGIC PARTNERSHIP    
        2.     MERGER & ACQUISITION    
    10. 10    COMPANY PROFILE    
      1.     EISAI, CO.
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      2.     MERCK & CO INC
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      3.     TAKEDA PHARMACEUTICAL COMPANY
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS
        4.     STRATEGY    
        5.     KEY DEVELOPMENT    
      4.     SANOFI
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW
        3.     FINANCIALS
        4.     KEY DEVELOPMENTS    
      5.     PFIZER, INC.
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      6.     OTHERS
    11.          CONCLUSION
    12. 12       Key Findings
      1.     FROM CEO’S VIEWPOINT 
        1.     UNMET NEEDS OF THE MARKET 
      2.       KEY COMPANIES TO WATCH
      3.       PREDICTION OF INSOMNIA CARE INDUSTRY
    13.     APPENDIX
    14.  

    Insomnia Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials